These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37455549)

  • 1. The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
    Zagami P; Comandone A; Fiore M; Baldi GG; Grignani G; Vincenzi B; Gronchi A; Antonarelli G; Boglione A; Pennacchioli E; Curigliano G; Conforti F; De Pas TM
    Cancer Med; 2023 Aug; 12(16):17047-17055. PubMed ID: 37455549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors and leiomyosarcomas.
    Katz SC; DeMatteo RP
    J Surg Oncol; 2008 Mar; 97(4):350-9. PubMed ID: 18286477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
    Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
    Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.
    Smrke A; Benson C; Strauss DC; Hayes AJ; Thway K; Hallin M; Fisher C; Messiou C; Huang PH; Jones RL; Smith MJ
    Eur J Surg Oncol; 2021 Oct; 47(10):2595-2601. PubMed ID: 33966946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
    Colombo C; Miceli R; Collini P; Radaelli S; Palassini E; Stacchiotti S; Fiore M; Mariani L; Casali PG; Gronchi A
    Cancer; 2012 Nov; 118(21):5349-57. PubMed ID: 22517186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.
    Hilal L; Barada K; Mukherji D; Temraz S; Shamseddine A
    Med Oncol; 2016 Feb; 33(2):20. PubMed ID: 26786155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications.
    Pérez-Gutiérrez S; González-Cámpora R; Amérigo-Navarro J; Beato-Moreno A; Sánchez-León M; Pareja Megía JM; Virizuela-Echaburu JA; López-Beltrán A
    Pathol Oncol Res; 2007; 13(3):203-8. PubMed ID: 17922049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
    Akin S; Dizdar O; Karakas Y; Turker A; Kars A
    Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.
    Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
    J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY
    Ann Oncol; 2021 Apr; 32(4):533-541. PubMed ID: 33482247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic uterine leiomyosarcomas: a single-institution experience.
    Bernstein-Molho R; Grisaro D; Soyfer V; Safra T; Merimsky O
    Int J Gynecol Cancer; 2010 Feb; 20(2):255-60. PubMed ID: 20134269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large national comparative study of clinicopathological features and long-term survivals between esophageal gastrointestinal stromal tumor and leiomyosarcoma.
    Azab B; Macedo FI; Cass SH; Ripat C; Razi SS; Picado O; Franceschi D; Livingstone AS; Yakoub D
    Am J Surg; 2019 Aug; 218(2):323-328. PubMed ID: 30471808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
    Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
    Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.
    Clary BM; DeMatteo RP; Lewis JJ; Leung D; Brennan MF
    Ann Surg Oncol; 2001 May; 8(4):290-9. PubMed ID: 11352301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.